Study to Evaluate the Safety and Efficacy of Long-Acting Capsid Inhibitor GS-6207 in Combination With Other Antiretroviral Agents in People Living With HIVmidwayadmin2020-05-15T15:08:12+00:00
Study to Evaluate the Safety and Efficacy of Long-Acting Capsid Inhibitor GS-6207 in Combination With Other Antiretroviral Agents in People Living With HIV
GS-US-200-4334 · Trial ·
Major Inclusion/Exclusion Criteria:
- Never been on HIV medication
- HIV RNA >500 copies
- CD4 >200
- No active Hepatitis B or Hepatitis C